Rttnews
Published October 15, 2026
NRx Pharmaceuticals Targets November FDA Deadline For Preservative-Free Ketamine
Read the full story at Rttnews
NRx Pharmaceuticals (NRXP) rose 6.52% after receiving an FDA letter requesting minor labeling changes for its preservative-free ketamine product.
Surfaced by this Google Alert
- Ketamine
